We offer the UK’s first non invasive, rapid endometriosis test.
With results in up to 30 minutes, this groundbreaking technology allows you to receive on the spot diagnosis, and to what extent, you may have endometriosis.
The Story..
This journey began with two highly respected gynaecologists, Nick and David, who have dedicated their careers to women’s health and wellbeing.
Nick and David have spent decades witnessing the challenges and frustrations faced by women suffering from endometriosis. Traditional diagnostic methods, often involving invasive procedures and prolonged waiting times, left many patients in pain and uncertainty. Their shared concern for these women and a desire to improve their quality of life sparked a quest for a better solution.
Determined to find a more efficient and compassionate way to diagnose endometriosis, Nick and David scoured the globe for innovative alternatives. Their search led them to the USA, where they discovered a groundbreaking new testing machine that promised to revolutionize endometriosis diagnosis. This advanced technology offered a non-invasive, quick, and highly accurate method for detecting endometriosis and assessing its severity within just 30 minutes.
The Process
The Science
Endometriosis is an inflammatory condition where the endometrial tissue produces various inflammatory mediators, including the potent prostaglandins PGE2 and PGF-2𝛼
Prostaglandins are absorbed into the bloodstream and circulate throughout the body, exerting their effects on various tissues. These mediators directly impact the gut, regardless of the location of the endometriosis, causing recognizable changes in the gut’s electrical signals.
EndoSure’s tricorder utilises unique technology to record electrical signals from the muscles of the small intestine. It generates a trace known as an EVG, or electroviscerogram, similar to an ECG, or electrocardiogram, for heart muscles. The prostaglandins PGE-2 and PGF-2𝛼 cause changes in intestinal motility, resulting in altered electrical activity.
The tricorder detects the electrical activity, decodes it, and converts it into a visible trace with a unique fingerprint characteristic of endometriosis. It utilizes sophisticated AI clinical decision support software to diagnose endometriosis based on these myo-electric signals.
A 30-minute recording of intestinal myo-electrical pulses after drinking a large volume of water is all that’s needed to establish the diagnosis. This technology, which has been around since the late 1990s and was first published in 1998, gained significant recognition in 2022. Dr. Noar, one of EndoSure’s founders, presented the first paper demonstrating the characteristic EVG changes caused by endometriosis at the American Association of Gynecologic Laparoscopy meeting.
